featured
Selinexor Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
J. Clin. Oncol 2023 Sep 05;[EPub Ahead of Print], I Vergote, JA Pérez-Fidalgo, EP Hamilton, G Valabrega, TV Gorp, J Sehouli, D Cibula, T Levy, S Welch, DL Richardson, EM Guerra, G Scambia, S Henry, P Wimberger, DS Miller, J Klat, J Martínez-Garcia, F Raspagliesi, B Pothuri, I Romero, A Bergamini, B Slomovitz, F Schochter, E Høgdall, L Fariñas-Madrid, BJ Monk, D Michel, MG Kauffman, S Shacham, MR Mirza, V MakkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.